These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 14473538)

  • 61. Histopathologic characteristics of scleromyxedema: A study of a series of 34 cases.
    Rongioletti F; Merlo G; Carli C; Cribier B; Metze D; Calonje E; Kempf W; Stefanato CM; Marinho E; Kanitakis J
    J Am Acad Dermatol; 2016 Jun; 74(6):1194-200. PubMed ID: 26897387
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Use of IGIV in the treatment of atopic dermatitis, urticaria, scleromyxedema, pyoderma gangrenosum, psoriasis, and pretibial myxedema.
    Jolles S; Hughes J
    Int Immunopharmacol; 2006 Apr; 6(4):579-91. PubMed ID: 16504920
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Scleromyxedema.
    Hummers LK
    Curr Opin Rheumatol; 2014 Nov; 26(6):658-62. PubMed ID: 25215418
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [A case of mononeuritis multiplex hypertrophicans in the Arndt-Gottron scleromyxedema. A contribution to the clinical picture of neuritic diseases in paraproteinemias].
    Hallen O
    Dtsch Z Nervenheilkd; 1969; 196(2):85-91. PubMed ID: 5800956
    [No Abstract]   [Full Text] [Related]  

  • 65. The pathogenesis of cutaneous myxedema.
    ASBOE-HANSEN G
    Arch Dermatol; 1960 Jul; 82():32-4. PubMed ID: 13794651
    [No Abstract]   [Full Text] [Related]  

  • 66. Scleromyxedema associated with non-Hodgkin lymphoma.
    Giménez Garcia R; Garcia SG; Suarez Vilela D; Moro Sanchez MJ
    Int J Dermatol; 1989 Dec; 28(10):670-1. PubMed ID: 2592130
    [No Abstract]   [Full Text] [Related]  

  • 67. [Scleromyxedema. --Studies on glycosaminoglycans (author's transl)].
    Takama H; Ohashi M; Iwata H
    Nihon Hifuka Gakkai Zasshi; 1976; 86(7):417-25. PubMed ID: 135108
    [No Abstract]   [Full Text] [Related]  

  • 68. Scleromyxedema.
    Chanda JJ
    Cutis; 1979 Nov; 24(5):549-52. PubMed ID: 520033
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Lichen myxedematosus: toward established classification and diagnostic criteria: Response to the letter 'Lichen myxedematosus: suggestions on the newly proposed diagnostic criteria'.
    Nofal A; Amer H; Alakad R
    Int J Dermatol; 2017 Apr; 56(4):e78. PubMed ID: 28133730
    [No Abstract]   [Full Text] [Related]  

  • 70. Lichen myxedematosus: how to reach the accurate diagnosis.
    Nofal A; Amer H; Nofal E
    Int J Dermatol; 2017 Sep; 56(9):e181-e182. PubMed ID: 28453183
    [No Abstract]   [Full Text] [Related]  

  • 71. [Disseminated mucinosis (scleromyxedema)].
    Kriner J; Rodriguez Quiroga JC
    Arch Argent Dermatol; 1968 Dec; 18(3):241-54. PubMed ID: 5758255
    [No Abstract]   [Full Text] [Related]  

  • 72. Dermatomyositis and lichen myxedematosus. A clinical, histopathological and electron microscopic study.
    Johnson BL; Horowitz IR; Charles CR; Cooper DL
    Dermatologica; 1973 Aug; 147(2):109-22. PubMed ID: 4754227
    [No Abstract]   [Full Text] [Related]  

  • 73. Scleromyxedema-like lesions of patients in renal failure contain hyaluronan: a possible pathophysiological mechanism.
    Neudecker BA; Stern R; Mark LA; Steinberg S
    J Cutan Pathol; 2005 Oct; 32(9):612-5. PubMed ID: 16176298
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Nephrogenic fibrosing dermopathy (scleromyxedema-like illness of renal disease).
    Mackay-Wiggan JM; Cohen DJ; Hardy MA; Knobler EH; Grossman ME
    J Am Acad Dermatol; 2003 Jan; 48(1):55-60. PubMed ID: 12522371
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Arndt-Gottron scleromyxedema].
    Berenbeĭn BA; Zhavoronkova TS
    Vestn Dermatol Venerol; 1977 Dec; (12):36-40. PubMed ID: 607682
    [No Abstract]   [Full Text] [Related]  

  • 76. Scleromyxedema: a complete response to prednisone.
    Rayson D; Lust JA; Duncan A; Su WP
    Mayo Clin Proc; 1999 May; 74(5):481-4. PubMed ID: 10319080
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Scleromyxedema with laryngeal changes. Beneficial results of the treatment with mucopolysaccharidases].
    Cosgarea R; Cosgarea M; Turcu T
    Ann Dermatol Venereol; 1994; 121(2):159-61. PubMed ID: 7979029
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The acquired cutaneous mucinoses.
    Matsuoka LY; Wortsman J; Carlisle KS; Kupchella CK; Dietrich JG
    Arch Intern Med; 1984 Oct; 144(10):1974-80. PubMed ID: 6486981
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Arndt-Gottron scleromyxedema and associated phenomena].
    Lang E; Zabel M; Schmidt H
    Dermatologica; 1984; 169(1):29-35. PubMed ID: 6432594
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Mucinosis].
    Kleine-Natrop HE; Jacobi H; Engel S
    Dermatol Monatsschr; 1969; 155(11):896-903. PubMed ID: 4244960
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.